The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community. Founded in 1991, the cancer center became a National Cancer Institute-designated comprehensive cancer center in 1997, one of only 42 institutions in the United States and two in Minnesota to hold that designation.
More than 500 faculty and staff are members of the Masonic Cancer Center. It is home to some of the world's top cancer researchers in bone marrow transplantation, breast cancer, bone cancer, cancer genetics, tobacco research, immunology, new therapies development, pediatric oncology, chemoprevention, and epidemiology.
- Research is organized into seven programs that focus on specific themes.
- The Cancer Information Line 1-888-CANCER MN (1-888-226-2376) is available for residents of Minnesota, Iowa, North Dakota, South Dakota, and Wisconsin.
- Through clinical trials, researchers learn which approaches are more effective than others.
- Program meetings, seminars, and other interdisciplinary meetings at the Masonic Cancer Center brings together experts from different fields to address the problem of cancer.
- Members can apply for internal grant mechanisms available through the Masonic Cancer Center Internal Grants Program which is offered on an annual basis. The overall goal of this program is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Cancer Center expects that these internal awards will lead to nationally peer reviewed funding.
News and Events
Masonic Cancer Center researchers identify mechanisms that determine aggressiveness of bone cancer
Researchers at the Masonic Cancer Center, University of Minnesota have published results of a study in the Journal of Biological Chemistry that defines a genetic mechanism that is responsible for the behavior of bone cancer, using findings from both canine and human bone cancer cells. This could help vets and physicians provided a more accurate prognosis for bone cancer patients and tailor therapies to treat tumors more effectively. Read more.
Program Support Funds now available
As the new academic year opens, we are pleased to announce a new funding initiative – the 2016 Masonic Cancer Center Program Support Funds program. Read more.
6th Annual Masonic Cancer Center Research Symposium
The Masonic Cancer Center Science Council announces its Sixth Annual Research Symposium November 10, 2015 in the Cancer and Cardiovascular Research Building from 10:30 a.m. to 4:00 p.m. Students, staff, postdocs and PIs are encouraged to participate and submit an abstract for the poster session. More information.